Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can motion sensors spot heart failure severity?

NCT ID NCT03909919

Knowledge-focused Sponsor: University of Malaga Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study from the University of Malaga tested whether motion sensors and 3D cameras can objectively measure movement problems in elderly people with heart failure. 34 participants (healthy and with heart failure) performed functional tasks while wearing a sensor and being recorded. The goal was to develop a new index combining movement data with other assessments to better classify patients by their level of impairment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple, objective way to measure functional impairment in elderly heart failure patients, helping doctors tailor care.
What could go wrong
This is a small, early-stage study (34 participants) focused on measurement tools, not a treatment. The new index may not prove useful in routine practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

34 people

The number who actually took part.

Started

Jan 2020

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects older than 70 years. * Healthy subjects and subjects diagnosed with Heart failure. * Subjects able of filling out questionnaires and performing functional tests. * subjects who are in a clinical stability and optimal treatment phase. Exclusion Criteria: * Participants with cardiac pathologies other than heart failure. * Score in the NYHA scale equal to 4. * Hospitalization in a period of time equal to or less than 3 months. * Score on the Mini-Mental scale below 24. * Inability to get up from the chair at least 5 times or 30 seconds. * Inability to walk for 6 minutes. * Inability to walk independently without a walking assistance device (cane, crutch or walker). * Subjects participating in an experimental study where they receive a treatment. * Inability to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

Contacts and locations

Locations

  • School Medicine University of Malaga

    Málaga, Malaga, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.